PMDA drug package insert
炭酸リチウム錠100mg「大正」
PMDA Prescription drug · 株式会社トクホン · package insert Jun 16, 2026
Key facts
| Brand names | 炭酸リチウム錠100mg「大正」, 炭酸リチウム錠200mg「大正」 |
|---|---|
| Nonproprietary names | 炭酸リチウム |
| Companies | 製造販売／株式会社トクホン, 販売／大正製薬株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 躁病・躁状態治療剤 |
| Therapeutic category codes | 871179 |
| YJ codes | 1179017F1080, 1179017F2087 |
| Approval numbers | 30400AMX00053000, 30400AMX00055000 |
| Package insert edition | 第6版 |
| Package insert date | Jun 16, 2026 |
| PMDA document key | 370035_1179017F1080_1 |
| PMDA company code | 370035 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- 1–9 Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: